|
Match
|
Document |
Document Title |
|
|
RE39149 |
Method of administering azithromycin
An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets;...
|
|
|
7056534 |
Coated potassium chloride granules and tablets
This invention provides extended release potassium chloride granules consisting essentially of potassium chloride crystals having a mesh size of about 20–60 mesh that are coated only with...
|
|
|
7045155 |
Dietary supplements comprising soy hypocotyls containing at least one isoflavone
Compositions enriched with natural phyto-oestrogens or analogues thereof selected from Genistein, Daidzein, Formononetin and Biochanin A. These may be used as food additives, tablets or capsules...
|
|
|
7041316 |
Stable oral pharmaceutical dosage forms
The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such...
|
|
|
7037525 |
Oxacarbazepine film-coated tablets
The invention relates to formulations, e.g. film-coated tablets containing oxcarbazepine and to processes for the production of said formulations. The film-coated tablets have a tablet core...
|
|
|
RE39069 |
Multi-layered osmotic device
The present invention provides a simple and improved multi-layered osmotic device ( 1 ) that is capable of delivering a first active agent in an outer lamina ( 2 ) to one environment of use and a...
|
|
|
7026160 |
Oral bacteriotherapy compositions and methods
A composition for treatment of renal failure with selected bacteria which converts nitrogenous waste into non-toxic compounds in vivo is provided. Also provided is a method of inhibiting build up...
|
|
|
7022341 |
Pharmaceutical compositions containing epinastine and pseudoephedrine
The present invention relates to novel oral pharmaceutical compositions comprising as pharmaceutically active compounds a combination of an antihistaminic-effective amount of epinastine or a...
|
|
|
7022342 |
Controlled release oral dosage form of beta-adrenergic blocking agents
A sustained release beta-adrenergic receptor blocking agent, preferably propranolol, formulation.
|
|
|
7022663 |
Oral, nasal and pulmonary dosage formulations of copolymer 1
Pharmaceutical compositions useful for treating autoimmune diseases in a mammal comprising as an active ingredient a therapeutically effective amount of Copolymer 1, and microcrystalline cellulose...
|
|
|
7014862 |
Chewable compositions containing a gel-forming extract of psyllium
Oral compositions, suitable for chewing, comprising a gel-forming polysaccharide isolated from psyllium seed husks and an excipient that is fast dissolving in the oral cavity, provide good...
|
|
|
7012129 |
Antiviral composition comprising glycine amide
Embodiments relate to the discovery that certain tripeptide amides and glycine amide can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More...
|
|
|
7011847 |
Enteric coated formulation for bisphosphonic acids and salts thereof
Pharmaceutical compositions and methods of using the composition are provided. The pharmaceutical composition comprises an inert core surrounded by an active coating containing one or more...
|
|
|
7008640 |
Pharmaceutical composition for oral use with improved absorption
The present invention presents a pharmaceutical composition for oral use with improved absorption, which comprises drug, aminoalkyl methacrylate copolymer E, and acidic substance and is obtained by...
|
|
|
6998139 |
Bitterness-reduced intrabuccally quick disintegrating tablets and method for reducing bitterness
The invention relates to a method for reducing bitterness of bitter drugs, which does not cause delay of release rate, does not show reduction of bioavailability in comparison with conventional...
|
|
|
6994873 |
Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
This invention refers to:
multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional...
|
|
|
6994872 |
Monolayer sugar-coated tablet and process for preparation thereof
This invention relates to a monolayer sugar-coated tablet which is coated with a sugar-coating liquid containing 30–54% by weight of saccharide, 2–10% by weight of polyethylene glycol and...
|
|
|
6988619 |
Medicinal product package for eradication therapy
The object of the present invention is to provide a medicinal product package which is suitable for microbe eradication therapy and with which the patient's compliance is increased and thus the...
|
|
|
6984399 |
Solid pharmaceutical formulation containing lovastatin and simvastatin respectively, and its preparation
The present invention relates to a novel solid pharmaceutical formulation containing lovastatin and simvastatin, respectively, with a particle size D(0.9) between 15 and 100 μm and a specific...
|
|
|
6979463 |
Stable extended release oral dosage composition
A film-coated extended release solid oral dosage composition containing a nasal decongestant, pseudoephedrine or salt thereof, e.g., pseudoephedrine sulfate in a core effective to provide a...
|
|
|
6974591 |
Method for producing a controlled-release preparation
The invention concerns a method for producing a controlled-release pharmaceutical preparation with a particle-containing coating, the coating being derived from an aqueous dispersion of a...
|
|
|
6964780 |
Controlled-release pharmaceutical formulations
The invention provides controlled-release formulations for oral administration containing a cGMP PDE-5 inhibitor. The formulations are useful, inter alia, in the treatment or prevention of sexual...
|
|
|
6964779 |
Tablet manufacturing method and tablet
According to the tablet production method of the present invention, tablet is produced by compressing molding material by means of punches and dies comprising the steps of using powdered or...
|
|
|
6962717 |
Pharmaceutical compositions
A pharmaceutical composition for slow release of active ingredient in the gastrointestinal tract, comprising a plurality of active ingredient-containing particles coated with a material insoluble...
|
|
|
6960356 |
Orally administered drug delivery system providing temporal and spatial control
A pharmaceutical composition in the form of tablets or capsules provides a combination of temporal and spatial control of drug delivery to a patient for effective therapeutic results. The...
|
|
|
6960357 |
Chemical delivery device
The invention provides a controlled release dissolution and diffusion devices which can deliver an active ingredient at a constant or controlled-variable rate comprising an active ingredient and...
|
|
|
6958161 |
Modified release coated drug preparation
A modified release preparation having one or more coated core elements, each core element including an active ingredient and having a modified release coating, wherein a stabilising coat is...
|
|
|
6949259 |
Solid preparations for oral use
Solid preparations for oral use for facilitating the administration in a small dose of KRP-297, which is a ligand common to peroxisome proliferator-activated receptors PPAR α and PPAR γ (i.e.,...
|
|
|
6946146 |
Coating for a sustained release pharmaceutical composition
The present invention is directed to a coating composition for coating a solid dosage form of a medicament, where the coating composition controls the release of the medicament, said coating...
|
|
|
6939560 |
Pharmaceutical composition having two coating layers
The present invention provides a pharmaceutical composition which is substantially free of unpleasant tastes and orally administrable which comprises:
(a) an active medicament, (b) an inner...
|
|
|
6932981 |
Rapidly disintegrating sustained release cefuroxime axetil composition
A fast disintegrating controlled release oral composition comprising a core material containing cefuroxime axetil present as controlled release form, the cefuroxime axetil being provided with an...
|
|
|
6926907 |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The dosage...
|
|
|
6923979 |
Method for depositing particles onto a substrate using an alternating electric field
Uniform portions of fine powders are deposited on a substrate by electrostatic attraction in which the charge of the electric field and polarity of the charged particles are varied repeatedly to...
|
|
|
6914141 |
Clopidogrel bisulfate tablet formulation
Pharmaceutical tablets comprising clopidogrel bisulfate and a lubricant selected from zinc stearate, stearic acid, and sodium stearyl fumarate.
|
|
|
6893662 |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a...
|
|
|
6890559 |
Directly compressible raw material for tablets
The present invention relates to an improved method of producing agglomerates and compressed products containing isomaltulose and/or hydrogenated isomaltulose.
|
|
|
6887492 |
Magnesium plus interactive agent delivery
The present invention is an orally administered pharmaceutical composition that provides for the controlled release of magnesium. The composition has an interactive agent component and a magnesium...
|
|
|
6869615 |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
An oral solid dosage form includes a therapeutically effective amount of an NSAID and a proton pump inhibitor in an amount effective to inhibit or prevent gastrointestinal side effects normally...
|
|
|
6866867 |
Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
The present invention provides an improved process for the preparation of a agglomerated solid dosage form, comprising: (1) preparing an aqueous slurry of (a) microcrystalline cellulose; (b) a...
|
|
|
6866866 |
Controlled release metformin compositions
A composition for treating patients having non-insulin-dependent diabetes mellitus (NIDDM) by administering a controlled release oral solid dosage form containing preferably a biguanide drug such...
|
|
|
6861066 |
Method for the delivery of a biologically active agent
A method of manufacturing a stable nanosuspension for delivery of a biologically active agent into the bloodstream of a subject is disclosed. A microfluidizable mixture is initially formed and...
|
|
|
6852335 |
Folic acid in solid dosage forms
A nutritional tablet or caplet has a film coating that contains folic acid available for rapid release upon contact with gastric fluid. The film coating also includes a film forming polymer such as...
|
|
|
6852336 |
Directly compressible high load acetaminophen formulations
Direct compressed solid pharmaceutical dosage forms containing:
a) from about 40 to about 95% by weight acetaminophen; b) from about 1 to about 60% by weight of a direct compression vehicle...
|
|
|
6838093 |
System for osmotic delivery of pharmaceutically active agents
An osmotic system for delivering a pharmaceutically active agent which comprises a core portion, a layer portion enclosing the core portion, and a semipermeable wall portion enclosing the core...
|
|
|
6838094 |
Tablet containing a coated core
A tablet formulation which comprises a core containing a pharmaceutically active material, coated with a release retarding coating, surrounded by a casing layer which includes a second...
|
|
|
6827946 |
Compositions containing both sedative and non-sedative antihistamines
Compositions comprising both a sedative and a non-sedative antihistamine are disclosed as well as methods of inhibiting the release of histamines by administration of the compositions to a...
|
|
|
6814979 |
Osmotic drug delivery system
Disclosed is an osmotic pharmaceutical delivery system comprising (a) a semi-permeable wall that maintains its integrity during pharmaceutical delivery and which has at least one passage...
|
|
|
6808721 |
Methods for coating pharmaceutical core tablets
A formulation comprising, and process for preparing, improved oral dosage forms of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin
-4-yl-ethoxy)-naphthalen-1-yl]-urea, a chemical...
|
|
|
6806294 |
Opioid analgesic
The invention is relative to a pharmaceutical preparation, especially for oral administration, with at least one active substance and with formulation components influencing the release of active...
|
|
|
6805881 |
Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
The present invention relates to orally administrable multiple-unit sustained-release dose forms having controlled agitation-independent release of active compound and processes for their...
|